A Portfolio of Good Medicine

Dear Investors,

Which Industry, other than IT Services, is India globally competitive?

In which industry are Indian products of high quality and reasonable cost on a global scale?

Which is the sector likely to do extremely well given today’s uncertainties?

The answer is – the Indian Pharma Sector.

JainMatrix Investments identified the pharma sector as attractive as the nation turns its attention to healthcare, hospitals and vaccines.
The Indian pharma firms have also been in focus globally, and the gates are opening slowly for these firms to win new markets, supply drugs & medicines and discover new cures.

We have made a report, Indian Pharmaceutical Sector – Good Medicine. Our report covers the following:

  • The progress of Indian pharma.
  • Why this sector is at an inflexion point in terms of global growth
  • Why this industry is globally competitive
  • The large cap and mid cap firms of interest
  • We benchmark a selection of the firms on financial parameters, across Large cap and Mid cap players. We sieve through them to find the preferred picks.
  • We map the share price performance of these firms over several years.
  • We provide a high quality portfolio of six firms of the Sector, 3 from large caps and 3 from mid caps, for investors.

Offer of the Month

  • Buy the JainMatrix Investments annual subscription for a special offer @ ₹15,999 (normal rates ₹16,999)
  • Get the Indian Pharma Sector report free along with the Welcome Kit and high performing Model Portfolios.
  • It includes a whole year of guidance on direct equity investing in Indian Markets. This offer is valid only for May 2021 as a special summer offer. See details
  • To take this offer, transfer in above offer amount on https://jainmatrix.com/payment-options/
  • Send a SMS message – Summer of ’21 Pharma offer/ your name to 9886110032.
  • Give us a day or two to contact you to start.

Happy investing !!

Regards,

Punit Jain – Founder, JainMatrix Investments

Disclaimer – While the offer is open in May ’21, we reserve our rights and may decline it in case our marketing objectives are not fulfilled.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s